Neuro-Degenerative Disease Clinical Trial
Official title:
Visualization of Neural Targets With 3T MRI
NCT number | NCT05175417 |
Other study ID # | 21-6105 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | January 29, 2022 |
Est. completion date | December 31, 2025 |
Functional neurosurgery is dedicated to modulating aberrant neural circuits associated with a wide range of neurological conditions. Recently, technological advances in MRI have permitted marked improvements in the direct visualization of neural targets, which is necessary for the accurate targeting in functional neurosurgery procedures. This research study focuses on imaging patient brains before their scheduled procedures by using a 3 tesla (T) MRI to provide higher resolution and quality brain images. The reason for this study is to assess the image quality using different MRI sequences or settings to improve the image resolution of the most common functional neurosurgery targets (e.g., subthalamic nucleus, globus pallidus, and thalamus) and compare the image quality of the brains in patients with healthy controls. Performing a preoperative MRI is standard-of-care for patients indicated for deep brain stimulation (DBS), gamma knife radiosurgery (GKRS), radiofrequency ablation (RFA), magnetic resonance-guided focused ultrasound (MRgFUS). MRI sequence parameters shown to improve the image quality of different neural structures in a recent literature review (Boutet et al. 2021) will be reproduced on the 3T MRI at Toronto Western Hospital.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | December 31, 2025 |
Est. primary completion date | August 29, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility | Inclusion Criteria: - Age between 18 and 85 years of age. - Preparing to undergo a functional neurosurgical intervention (e.g., DBS, RFA, GKR or MRgFUS) at TWH (not applicable for healthy volunteers). - Participants must be able to understand the purpose of this research and must sign the informed consent form. - Participants must understand that the role of this research is to enhance our understanding of brain functioning and that he/she will not directly or indirectly benefit from the study. Exclusion Criteria: - Contraindication for an MRI (e.g., implanted cardiac device, metal in eyes, aneurysm clip, etc.). - Participants who have serious cognitive or psychological impairments and cannot give informed consent. - Participants who are unable to communicate effectively or efficiently (e.g., patients suffering from speech deficits (dysarthria, aphasia) or are non-English speaking). |
Country | Name | City | State |
---|---|---|---|
Canada | Toronto Western Hospital | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
University Health Network, Toronto |
Canada,
Boutet A, Loh A, Chow CT, Taha A, Elias GJB, Neudorfer C, Germann J, Paff M, Zrinzo L, Fasano A, Kalia SK, Steele CJ, Mikulis D, Kucharczyk W, Lozano AM. A literature review of magnetic resonance imaging sequence advancements in visualizing functional neurosurgery targets. J Neurosurg. 2021 Mar 26;135(5):1445-1458. doi: 10.3171/2020.8.JNS201125. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quantitative image quality metrics | Two quantitative image quality metrics commonly used are contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR). CNR (i.e., the ratio of the contrast between the signal in a given region and the background) is a measure of the contrast between the tissue of interest and the neighboring tissue. Similarly, SNR is a measure of the average image signal in a given region to the neighboring tissue or the noise around the region of interest. | = 1 week before surgery | |
Primary | Qualitative image quality metrics | Qualitative image quality metrics will assess the image quality and clinical acceptability of each scan in a randomized order. Each scan will be scored using a 5-point Likert scale by expert raters. An overall average score will be calculated for each MRI sequence. | = 1 week before surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05586750 -
Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy
|
Phase 4 | |
Completed |
NCT04050800 -
Carbon-11 Butanol: Whole Body Radiochemical and Radiation Safety
|
Early Phase 1 | |
Recruiting |
NCT04863859 -
Persons With Dementia and Their Extended Family Caregivers
|
||
Recruiting |
NCT05655650 -
Identifying Biomarkers in Alzheimer's Disease
|
||
Completed |
NCT04937127 -
Efficiency of E-learning and Role-playing for the Training of Nursing Home Caregivers in the Support of Agitation in Neurodegenerative Diseases
|
||
Enrolling by invitation |
NCT03197363 -
BiaĆystok PLUS - Polish Longitudinal University Study
|
||
Enrolling by invitation |
NCT03322306 -
Establishment of Genetic Basis for Neurological Disease by Genetic Screening
|
||
Completed |
NCT03439163 -
Large Sample PD Patients and Healthy Controls
|
N/A | |
Withdrawn |
NCT05921929 -
First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM)
|
Phase 1 | |
Recruiting |
NCT05209698 -
Self-Management Behaviors of Arabs and Jews With Parkinson's Disease and Their Associations With Health Outcomes
|
||
Completed |
NCT04362228 -
The Effects of Whole-body Exercise to Improve Swallowing Function in Older Adults With Dementia
|
N/A | |
Enrolling by invitation |
NCT05008094 -
The Epidemiology of Parkinson's Disease in Croatia and the Influence of Genetic Factors and Microbiota on the Progression and Treatment Outcomes of the Disease (GiOPARK)
|
||
Completed |
NCT03279991 -
Neuromed- Integrated Health Life Platform and Biobank
|
||
Active, not recruiting |
NCT04228653 -
Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions
|
Phase 1/Phase 2 | |
Recruiting |
NCT05328492 -
Volume Mode Non-invasive Ventilation in Amyotrophic Lateral Sclerosis
|
N/A | |
Not yet recruiting |
NCT06151600 -
A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J
|
||
Recruiting |
NCT04880356 -
Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
|
||
Active, not recruiting |
NCT03609125 -
Cord Blood Serum in the Treatment of Neuro-Degenerative Ophthalmic Diseases. 1-Glaucoma
|
N/A | |
Recruiting |
NCT03153670 -
3T MRI in Patients With Deep Brain Stimulation (DBS)
|
N/A | |
Completed |
NCT03775538 -
Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study
|
Phase 1/Phase 2 |